InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by WHITFIELD ROY A, Director. Insider active across 1 company, notably NEKTAR THERAPEUTICS. Cumulatively, 4 disclosures have been published. History available since 16 September 2021. The latest transaction was disclosed on 22 September 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
10,200 shares0Common StockSEC:0001209191-21-057708:0
10,200 shares0Common StockSEC:0001209191-21-057708
40,000 shares@ US$13.800.020% mcap50.0% of flowCommon StockSEC:0001209191-21-056728:0
40,000 shares@ US$13.800.020% mcap100.0% of flowCommon StockSEC:0001209191-21-056728
4 of 4 declarations
About WHITFIELD ROY A
Roy A. Whitfield is a Board Member of Nektar Therapeutics. He participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset to the board.
